title: Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.
abstract: Tick-borne encephalitis (TBE) is caused by an arthropod-borne virus, belonging to the family of Flaviviridae. In case of disease, which can lead to neurological sequelae or even fatal outcomes, only symptomatic treatment is available. TBE can be prevented by vaccination. Various primary immunization schedules have been developed. To identify the most suitable schedule, the present randomised, controlled study was designed to provide data on the immune response elicited by four different immunization schedules obtained by ELISA and by neutralization test (NT). A total of 398 healthy subjects aged > or =12 years were randomised to vaccination according to either the rapid schedule (Group R, vaccination on days 0, 7 and 21), the conventional schedule (Group C, vaccination on days 0, 28 and 300), the modified conventional schedule (Group M, vaccination on days 0, 21 and 300) or the accelerated conventional schedule (Group A, vaccination on days 0, 14 and 300). Within 3 weeks (i.e. by day 21) antibody levels were higher in Group R and Group A than in Group M and Group C. Group R and Group C both had higher titres on days 42, 180 and 300, than Group A and Group M. The rapid schedule thus combines the advantages of fast protection and of high titres over the observation period of 300 days.
authors.affiliation: Novartis Vaccines and Diagnostics GmbH and Co. KG, Clinical Research and Medical Affairs, Emil-von-Behring-Str. 76, 35041 Marburg, Germany. ines_schoendorf@chiron.com
authors.forename: I
authors.initials: I
authors.lastname: Schöndorf
authors.forename: J
authors.initials: J
authors.lastname: Beran
authors.forename: D
authors.initials: D
authors.lastname: Cizkova
authors.forename: V
authors.initials: V
authors.lastname: Lesna
authors.forename: A
authors.initials: A
authors.lastname: Banzhoff
authors.forename: O
authors.initials: O
authors.lastname: Zent
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D004669:Encephalitis Viruses, Tick-Borne / Q000276:immunology*; D004675:Encephalitis, Tick-Borne / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D008297:Male; D008875:Middle Aged; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology
chemical_list: D014765:Viral Vaccines